HRP20182163T8 - Formulacija parvovirusa za liječenje tumora - Google Patents
Formulacija parvovirusa za liječenje tumoraInfo
- Publication number
- HRP20182163T8 HRP20182163T8 HRP20182163TT HRP20182163T HRP20182163T8 HR P20182163 T8 HRP20182163 T8 HR P20182163T8 HR P20182163T T HRP20182163T T HR P20182163TT HR P20182163 T HRP20182163 T HR P20182163T HR P20182163 T8 HRP20182163 T8 HR P20182163T8
- Authority
- HR
- Croatia
- Prior art keywords
- treating tumors
- parvovirus
- formulation
- parvovirus formulation
- tumors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173308.6A EP3108892A1 (en) | 2015-06-23 | 2015-06-23 | Parvovirus formulation for treating tumors |
| PCT/EP2016/059832 WO2016206844A1 (en) | 2015-06-23 | 2016-05-03 | Parvovirus formulation for treating tumors |
| EP16725045.5A EP3277299B1 (en) | 2015-06-23 | 2016-05-03 | Parvovirus formulation for treating tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20182163T1 HRP20182163T1 (hr) | 2019-03-08 |
| HRP20182163T8 true HRP20182163T8 (hr) | 2020-02-07 |
Family
ID=53488216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20182163TT HRP20182163T8 (hr) | 2015-06-23 | 2018-12-20 | Formulacija parvovirusa za liječenje tumora |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US10624935B2 (hr) |
| EP (2) | EP3108892A1 (hr) |
| JP (1) | JP6423113B2 (hr) |
| KR (1) | KR102046239B1 (hr) |
| CN (1) | CN107921075B (hr) |
| AU (1) | AU2016284497B2 (hr) |
| BR (1) | BR112017025157B1 (hr) |
| CA (1) | CA2990749C (hr) |
| CL (1) | CL2017003338A1 (hr) |
| CY (1) | CY1121020T1 (hr) |
| DK (1) | DK3277299T3 (hr) |
| ES (1) | ES2702526T3 (hr) |
| HK (1) | HK1254253B (hr) |
| HR (1) | HRP20182163T8 (hr) |
| HU (1) | HUE041557T2 (hr) |
| IL (1) | IL255952B (hr) |
| LT (1) | LT3277299T (hr) |
| MX (1) | MX2017014897A (hr) |
| NZ (1) | NZ737222A (hr) |
| PL (1) | PL3277299T3 (hr) |
| PT (1) | PT3277299T (hr) |
| RS (1) | RS58096B1 (hr) |
| RU (1) | RU2698717C2 (hr) |
| SA (1) | SA517390457B1 (hr) |
| SI (1) | SI3277299T1 (hr) |
| TR (1) | TR201819816T4 (hr) |
| WO (1) | WO2016206844A1 (hr) |
| ZA (1) | ZA201707502B (hr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3225253A1 (en) * | 2016-04-01 | 2017-10-04 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030092145A1 (en) * | 2000-08-24 | 2003-05-15 | Vic Jira | Viral vaccine composition, process, and methods of use |
| DK2082745T3 (da) | 2007-12-28 | 2013-03-25 | Deutsches Krebsforsch | Kræftterapi med en parvovirus kombineret med kemoterapi |
| EP2332986B1 (en) * | 2009-12-11 | 2013-10-09 | Deutsches Krebsforschungszentrum | Antibody that binds to H-1 parvovirus |
| EP2366398A1 (en) | 2010-03-17 | 2011-09-21 | Deutsches Krebsforschungszentrum | Cancer therapy with a parvovirus combined with an HDAC inhibitor |
| EP2397542A1 (en) * | 2010-06-17 | 2011-12-21 | Deutsches Krebsforschungszentrum | Modified parvovirus having enhanced anti-tumour efficacy |
-
2015
- 2015-06-23 EP EP15173308.6A patent/EP3108892A1/en not_active Withdrawn
-
2016
- 2016-05-03 KR KR1020177036934A patent/KR102046239B1/ko active IP Right Grant
- 2016-05-03 PT PT16725045T patent/PT3277299T/pt unknown
- 2016-05-03 TR TR2018/19816T patent/TR201819816T4/tr unknown
- 2016-05-03 NZ NZ73722216A patent/NZ737222A/en unknown
- 2016-05-03 CA CA2990749A patent/CA2990749C/en active Active
- 2016-05-03 CN CN201680036327.1A patent/CN107921075B/zh active Active
- 2016-05-03 WO PCT/EP2016/059832 patent/WO2016206844A1/en active Application Filing
- 2016-05-03 BR BR112017025157-4A patent/BR112017025157B1/pt active IP Right Grant
- 2016-05-03 ES ES16725045T patent/ES2702526T3/es active Active
- 2016-05-03 HU HUE16725045A patent/HUE041557T2/hu unknown
- 2016-05-03 EP EP16725045.5A patent/EP3277299B1/en active Active
- 2016-05-03 RU RU2017139565A patent/RU2698717C2/ru active
- 2016-05-03 RS RS20181557A patent/RS58096B1/sr unknown
- 2016-05-03 AU AU2016284497A patent/AU2016284497B2/en active Active
- 2016-05-03 JP JP2017566665A patent/JP6423113B2/ja active Active
- 2016-05-03 LT LTEP16725045.5T patent/LT3277299T/lt unknown
- 2016-05-03 SI SI201630142T patent/SI3277299T1/sl unknown
- 2016-05-03 MX MX2017014897A patent/MX2017014897A/es active IP Right Grant
- 2016-05-03 PL PL16725045T patent/PL3277299T3/pl unknown
- 2016-05-03 DK DK16725045.5T patent/DK3277299T3/en active
-
2017
- 2017-11-06 ZA ZA2017/07502A patent/ZA201707502B/en unknown
- 2017-11-27 IL IL255952A patent/IL255952B/en active IP Right Grant
- 2017-11-30 SA SA517390457A patent/SA517390457B1/ar unknown
- 2017-12-04 US US15/830,489 patent/US10624935B2/en active Active
- 2017-12-22 CL CL2017003338A patent/CL2017003338A1/es unknown
-
2018
- 2018-10-18 HK HK18113397.2A patent/HK1254253B/zh unknown
- 2018-12-19 CY CY181101367T patent/CY1121020T1/el unknown
- 2018-12-20 HR HRP20182163TT patent/HRP20182163T8/hr unknown
-
2020
- 2020-03-20 US US16/824,791 patent/US11324788B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL260443B (en) | Combinations of anti-egfr for cancer treatment | |
| IL246680A0 (en) | Materials and preparations for the treatment of her2-positive tumors | |
| HUE059694T2 (hu) | Készítmény rák kezelésére | |
| IL260442B (en) | Combinations of anti-cd20 for cancer treatment | |
| SG11201705093UA (en) | Composition for treating il-6-related diseases | |
| IL255060A0 (en) | Combined treatment for cancer | |
| HUE046505T2 (hu) | Antitestkészítmények daganatkezelésre | |
| IL259864A (en) | Monomaleimide-functionalized platinum compounds for cancer therapy | |
| ZA201707737B (en) | Composition for treating brain lesions | |
| ZA201707813B (en) | Composition for treating tissue lesions | |
| HK1248130A1 (zh) | 用於治療疼痛的組合物 | |
| ZA201707024B (en) | Cancer treatment composition | |
| HRP20182163T8 (hr) | Formulacija parvovirusa za liječenje tumora | |
| HUE051563T2 (hu) | Gyógyszerkészítmény rák megelõzésére vagy kezelésére | |
| HK1259615A1 (zh) | 谷氨酸-高z元素化合物治療癌症 | |
| IL255167A0 (en) | Compounds for the treatment of cancer | |
| HK1256371A1 (zh) | 用於治療腫瘤的方法 | |
| GB201511895D0 (en) | Combination therapy for treating multiple sclerosis | |
| GB201510658D0 (en) | Compositions for wound treatment |